Lifeward Ltd. (LFWD)
Nasdaq · Healthcare · Medical Devices
$6.67+14.02%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $18.9M
- 52-week range
- $4.14 – $10.13
- 52-week change
- −38.99%
- EPS (trailing)
- −$15.73
- Next earnings
- Nov 12, 2026
Fiscal year to Dec 2025
- Revenue
- $22.0M (−14.14%)
- Net income
- −$19.9M
- Operating margin
- −89.3%
- Diluted EPS
- −$17.16
- Free cash flow
- −$16.8M
From the company’s annual report on SEC EDGAR.
About Lifeward Ltd.
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.
Headquarters: Yokneam Illit, Israel · 81 employees · golifeward.com